AllianceBernstein
MBII

AllianceBernstein’s Marrone Bio Innovations, Inc. MBII Stock Holding History

AllianceBernstein’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,500
Closed -$18K – 3231
2020
Q2 		$18K Buy
15,500
+3,600
+30% +$3.33K ﹤0.01% 3190
2020
Q1 		$10K Buy
+11,900
New +$12.6K ﹤0.01% 3121
2014
Q2 		– Sell
-132
Closed -$2K – 3695
2014
Q1 		$2K Hold
132
– – ﹤0.01% 3473
2013
Q4 		$2K Hold
132
– – ﹤0.01% 3266
2013
Q3 		$2K Buy
+132
New +$1.85K ﹤0.01% 3286

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AllianceBernstein's MBII Position: Q3 2020 in Review

AllianceBernstein sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2020, closing a stake of 15,500 shares — an estimated $18K sold.

AllianceBernstein first reported a position in MBII in Q3 2013 and held it in 5 quarters. The position peaked at $18K in Q2 2020. 58 funds tracked by Wall St. Rank hold MBII as of Q3 2020.

  • AllianceBernstein reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2020 after selling out during the quarter.
  • AllianceBernstein sold 15,500 Marrone Bio Innovations, Inc. shares in Q3 2020, an estimated $18K.
  • AllianceBernstein first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 5 quarters.
  • AllianceBernstein's Marrone Bio Innovations, Inc. position peaked at $18K in Q2 2020.
  • 58 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2020.

Based on AllianceBernstein's 13F filing for Q3 2020, filed 12 Nov 2020.